CTLA-4 and PD-1 Antibodies Expressing Mesothelin-CAR-T Cells for Mesothelin Positive Advanced Solid Tumor
Clinical trial NCT03182803 · UNKNOWN
Trial details
- NCT number
- NCT03182803
- Sponsor
- Shanghai Cell Therapy Research Institute
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-07
- Primary completion
- 2019-01-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.